In conclusion, miR-372-3p KD might protect against DCM by accelerating angiogenesis through activating the PI3K/AKT/mTOR/HIF-1α signaling pathway or suppressing oxidative stress. The gene discussed is HIF1A; the disease is familial dilated cardiomyopathy.